Top news of the week: 02.08.2022.
Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs
Biotech investors look at hundreds of startups each year, trying to find the best new companies. Here are the privately held, venture-backed businesses they think will take off.
Strand CEO on founder-led biotech, venture capital and the market’s retreat
Jake Becraft, founder and current chief of mRNA startup Strand Therapeutics, argues biotech would be healthier if more scientists and researchers lead the companies they start.
Novartis-linked startup launches with technology designed to remove ‘destroy’ tags on helpful proteins
Vicinitas and its protein-stabilizing research have attracted $65 million from a group of investors that includes a16z, Deerfield and GV.
Alexis Borisy, biotech’s ‘man of many hats,’ dons another
IDRx is starting off with $122 million and two licensed drug candidates it plans to combine to create a treatment for gastrointestinal stromal tumors, or GIST.
Clay Siegall built Seattle biotech firm Seagen into a $1.6B giant. Then the cops came calling
Seagen chief Clay Siegall quit after an arrest at his home. Now, records obtained by The Seattle Times show it wasn't the first time cops came.
Versant partners with AbCellera to arm startups with better antibodies
The companies pitch their collaboration as a way to give young drugmakers backed by Versant a head start. “Our business is advanced by great ideas coming into the funnel,” said AbCellera’s ...
Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects
Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects - read this article along with other careers information, tips and advice on ...
This billionaire has quietly driven Boston’s biotech industry for decades
He set in motion a series of events that created the company Moderna — and committed to being its first investor. But he still regularly rides his bike to work, and he “never viewed science ...